节点文献

路优泰与万拉法新治疗轻中度抑郁症60例对照研究

A Control Study of Neurostan and Venlafaxine in Mild Depression

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 王东平; 李予春; 卢爱莲; 冯砚国; 王世贵; 王云;

【Author】 Wang Dongping, Li Yuchun, Lu Ailian, et al. The Second Affiliated Hospital of Xinxiang Medical College, 453002 P.R.China

【机构】 中国.河南省新乡医学院第二附属医院普通精神一科; 中国.河南省新乡医学院第二附属医院普通精神一科 453002; 453002;

【摘要】 目的探讨路优泰对轻中度抑郁症患者的疗效及安全性。方法将60例抑郁症患者随机分为路优泰组和万拉法新组,治疗6周,采用汉密尔顿抑郁(HAMD)、汉密尔顿焦虑量表(HAMA)和副反应量表(TESS)评定疗效和不良反应。结果路优泰有效率为80%,对抑郁及伴随的焦虑症状作用明显,不良反应较少。结论路优泰对轻中度抑郁疗效肯定,与万拉法新相当,安全性较好。

【Abstract】 Objective To study the efficacy and side effect of neurostan in the treatment of patients with mild depression. Methods 60 patients with mild depression were randomly divided into neurostan and venlafaxine for 6 weeks. The therapeutic response and side effects were evaluated with the Hamilton depressive scale (HAMD). Hamilton anxiety scale (HAMA) and treatment emernent symptom scale (TESS). Results The efficacy rate of neurostan was 80%, and neurostan is markedly effective in the treatment of mild depression and anxiety symptom, with fewer and slight side effects. Conclusion Neurostan is exactly effective in the treatment of depression, and efficacy is similar to that of venlafaxine with fewer side effects.

【关键词】 精神病学; 路优泰; 万拉法新; 抑郁症;
【Key words】 Psychiatry; Neurostan; Venlafaxine; Depression;
  • 【文献出处】 中国健康心理学杂志 ,China Journal of Health Psychology , 编辑部邮箱 ,2006年05期
  • 【分类号】R749.4
  • 【被引频次】5
  • 【下载频次】115
节点文献中: 

本文链接的文献网络图示:

本文的引文网络